These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Merz M; Kroll R; Lynen R; Bangerter K Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585 [TBL] [Abstract][Full Text] [Related]
3. Long-term contraceptives. Brown A Best Pract Res Clin Obstet Gynaecol; 2010 Oct; 24(5):617-31. PubMed ID: 20558111 [TBL] [Abstract][Full Text] [Related]
4. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Elaut E; Buysse A; De Sutter P; De Cuypere G; Gerris J; Deschepper E; T'Sjoen G Contraception; 2012 May; 85(5):470-9. PubMed ID: 22133661 [TBL] [Abstract][Full Text] [Related]
5. A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Gruber D; Skřivánek A; Serrani M; Lanius V; Merz M Contraception; 2015 Feb; 91(2):105-12. PubMed ID: 25453582 [TBL] [Abstract][Full Text] [Related]
6. Comparing patient telephone callback rates for different hormonal birth control delivery systems. Victor I; Fink RA Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531 [TBL] [Abstract][Full Text] [Related]
12. The transdermal patch and the vaginal ring: two novel methods of combined hormonal contraception. Swica Y Obstet Gynecol Clin North Am; 2007 Mar; 34(1):31-42, viii. PubMed ID: 17472863 [TBL] [Abstract][Full Text] [Related]
13. Choice of contraceptives. Med Lett Drugs Ther; 2015 Sep; 57(1477):127-32. PubMed ID: 26353044 [No Abstract] [Full Text] [Related]
15. Hormonal contraception: recent advances and controversies. Practice Committee of American Society for Reproductive Medicine Fertil Steril; 2008 Nov; 90(5 Suppl):S103-13. PubMed ID: 19007605 [TBL] [Abstract][Full Text] [Related]
16. Role of progestins in contraception. Erkkola R; Landgren BM Acta Obstet Gynecol Scand; 2005 Mar; 84(3):207-16. PubMed ID: 15715527 [TBL] [Abstract][Full Text] [Related]
17. Progress in contraception: new technology. Linn ES Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551 [TBL] [Abstract][Full Text] [Related]
18. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology. Gourdy P; Bachelot A; Catteau-Jonard S; Chabbert-Buffet N; Christin-Maître S; Conard J; Fredenrich A; Gompel A; Lamiche-Lorenzini F; Moreau C; Plu-Bureau G; Vambergue A; Vergès B; Kerlan V Ann Endocrinol (Paris); 2012 Nov; 73(5):469-87. PubMed ID: 23078975 [TBL] [Abstract][Full Text] [Related]
19. [Contraceptions in women with contra-indication to estrogen-progestins]. Gompel A Rev Prat; 1995 Dec; 45(19):2431-4. PubMed ID: 8571055 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic Therapies in Women's Health: Contraception and Menopause Treatment. Allen C; Evans G; Sutton EL Med Clin North Am; 2016 Jul; 100(4):763-89. PubMed ID: 27235614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]